Quick Answer American Bitcoin Corp. reported Diluted EPS of $0.17 per share (loss) for fiscal year 2025. American Bitcoin Corp. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.17 -134.7% 2024 $0.49 +1125.0% 2023 $0.04 +100.0% 2022 -$546.56 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ June 30, 2025 … Read more
Quick Answer American Bitcoin Corp. reported Total Assets of $1.25 billion for fiscal year 2025. American Bitcoin Corp. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $1.25B +12.7% 2024 $1.11B +5774.5% 2023 $18.83M -3.3% 2022 $19.47M -79.4% 2021 $94.48M +22.4% 2020 $77.17M +31.8% 2020 $58.53M +141.8% 2019 $24.20M — Quarterly Total … Read more
Quick Answer American Bitcoin Corp. reported Net Income of -$153.17 million for fiscal year 2025. American Bitcoin Corp. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$153.17M -135.7% 2024 $428.94M +982.8% 2023 $39.61M +150.1% 2022 -$79.06M -152.3% 2021 -$31.33M -130.8% 2020 -$13.57M -9.4% 2019 -$12.40M — Quarterly Net Income Quarter Ending … Read more
Quick Answer American Bitcoin Corp. reported Total Revenue of $185.16 million for fiscal year 2025. American Bitcoin Corp. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $185.16M +158.8% 2024 $71.54M +10.1% 2023 $64.98M +521.3% 2022 $10.46M -40.7% 2021 $17.63M +634.5% 2021 $2.40M -80.9% 2020 $12.57M +16.2% 2019 $10.82M +3.3% 2018 $10.48M … Read more
Quick Answer American Bitcoin Corp. reported Total Revenue of $185.16 million for fiscal year 2025. American Bitcoin Corp. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $185.16M+158.8% $71.54M+10.1% $64.98M+521.3% $10.46M+335.8% $2.40M-80.9% $12.57M+16.2% Net Income -$153.17M-135.7% $428.94M+982.8% $39.61M+150.1% -$79.06M-152.3% -$31.33M-130.8% -$13.57M-9.4% Diluted EPS -$0.17-134.7% $0.49+1125.0% $0.04+100.0% -$546.56 — — Total … Read more
Quick Answer ABBOTT LABORATORIES reported Operating Income of $8.05 billion for fiscal year 2025. ABBOTT LABORATORIES Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $8.05B +18.0% 2024 $6.83B +5.4% 2023 $6.48B -22.5% 2022 $8.36B -0.7% 2021 $8.43B +57.3% 2020 $5.36B +18.2% 2019 $4.53B +24.2% 2018 $3.65B +133.4% 2017 $1.56B -48.3% 2016 … Read more
Quick Answer ABBOTT LABORATORIES reported R&D Expense of $2.94 billion for fiscal year 2025. ABBOTT LABORATORIES R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $2.94B +3.4% 2024 $2.84B +3.8% 2023 $2.74B -5.1% 2022 $2.89B +5.3% 2021 $2.74B +13.3% 2020 $2.42B -0.8% 2019 $2.44B +6.1% 2018 $2.30B +1.8% 2017 $2.26B — Quarterly … Read more
Quick Answer ABBOTT LABORATORIES reported Stockholders Equity of $52.13 billion for fiscal year 2025. ABBOTT LABORATORIES Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $52.13B +9.4% 2024 $47.66B +23.5% 2023 $38.60B +5.2% 2022 $36.69B +2.5% 2021 $35.80B +9.2% 2020 $32.78B +5.5% 2019 $31.09B +1.8% 2018 $30.52B -1.2% 2017 $30.90B +50.4% 2016 … Read more
Quick Answer ABBOTT LABORATORIES reported Long-Term Debt of $9.90 billion for fiscal year 2025. ABBOTT LABORATORIES Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $9.90B -21.6% 2024 $12.62B -7.2% 2023 $13.60B -6.4% 2022 $14.52B -16.0% 2021 $17.30B -6.6% 2020 $18.53B +11.2% 2019 $16.66B -13.9% 2018 $19.36B -28.9% 2017 $27.21B +31.6% 2016 … Read more
Quick Answer ABBOTT LABORATORIES reported Cash and Equivalents of $8.52 billion for fiscal year 2025. ABBOTT LABORATORIES Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $8.52B +11.9% 2024 $7.62B +10.4% 2023 $6.90B -30.2% 2022 $9.88B +0.8% 2021 $9.80B +43.3% 2020 $6.84B +77.2% 2019 $3.86B +0.4% 2018 $3.84B -59.1% 2017 … Read more